China Capital Surpluse from 2010 to 2025

CJJD Stock  USD 1.61  0.08  5.23%   
China Jo's Capital Surpluse is increasing over the years with slightly volatile fluctuation. Overall, Capital Surpluse is expected to go to about 80.3 M this year. During the period from 2010 to 2025 China Jo Capital Surpluse annual values regression line had geometric mean of  37,649,560 and mean square error of 32.3 T. View All Fundamentals
 
Capital Surpluse  
First Reported
2011-06-30
Previous Quarter
66.5 M
Current Value
66.5 M
Quarterly Volatility
17.7 M
 
Yuan Drop
 
Covid
Check China Jo financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among China Jo's main balance sheet or income statement drivers, such as Interest Expense of 11.6 K, Other Operating Expenses of 97.3 M or EBITDA of 1.2 M, as well as many indicators such as Price To Sales Ratio of 0.0331, Dividend Yield of 0.0 or PTB Ratio of 33 K. China financial statements analysis is a perfect complement when working with China Jo Valuation or Volatility modules.
  
Check out the analysis of China Jo Correlation against competitors.

Latest China Jo's Capital Surpluse Growth Pattern

Below is the plot of the Capital Surpluse of China Jo Jo Drugstores over the last few years. It is China Jo's Capital Surpluse historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in China Jo's overall financial position and show how it may be relating to other accounts over time.
Capital Surpluse10 Years Trend
Slightly volatile
   Capital Surpluse   
       Timeline  

China Capital Surpluse Regression Statistics

Arithmetic Mean44,451,991
Geometric Mean37,649,560
Coefficient Of Variation53.82
Mean Deviation20,796,839
Median44,905,664
Standard Deviation23,921,979
Sample Variance572.3T
Range63.7M
R-Value0.97
Mean Square Error32.3T
R-Squared0.95
Slope4,890,512
Total Sum of Squares8583.9T

China Capital Surpluse History

202580.3 M
202476.5 M
202066.5 M
201954.2 M
201844.9 M
201743.6 M
201636.6 M

About China Jo Financial Statements

China Jo stakeholders use historical fundamental indicators, such as China Jo's Capital Surpluse, to determine how well the company is positioned to perform in the future. Although China Jo investors may analyze each financial statement separately, they are all interrelated. For example, changes in China Jo's assets and liabilities are reflected in the revenues and expenses on China Jo's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in China Jo Jo Drugstores. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Capital Surpluse76.5 M80.3 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether China Jo Jo is a strong investment it is important to analyze China Jo's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact China Jo's future performance. For an informed investment choice regarding China Stock, refer to the following important reports:
Check out the analysis of China Jo Correlation against competitors.
You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Is Consumer Staples Distribution & Retail space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of China Jo. If investors know China will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about China Jo listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.31)
Revenue Per Share
41.614
Quarterly Revenue Growth
(0.09)
Return On Assets
(0.04)
Return On Equity
(0.30)
The market value of China Jo Jo is measured differently than its book value, which is the value of China that is recorded on the company's balance sheet. Investors also form their own opinion of China Jo's value that differs from its market value or its book value, called intrinsic value, which is China Jo's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because China Jo's market value can be influenced by many factors that don't directly affect China Jo's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between China Jo's value and its price as these two are different measures arrived at by different means. Investors typically determine if China Jo is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, China Jo's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.